liver disease
Swiss Agency Provides CHF 475K to Versantis to Develop POC Blood Ammonia Test
The company will use the ZHAW School of Engineering to develop a prototype device based on a polymersome ammonia quantification method.
The three-biomarker blood test is being made available for the first time to US hepatologists and other clinicians to assess liver disease due to NASH.
Becton Dickinson, Siemens Healthineers, Abbott Laboratories, Others Nab FDA Clearances in November
BioMérieux obtained FDA clearance for a multiplex RT-PCR assay that detects SARS-CoV-2 RNA in nasopharyngeal swabs from symptomatic individuals.
FDA Grants De Novo Authorization for Siemens Healthineers' Enhanced Liver Fibrosis Blood Test
The ELF Test provides prognostic information to assess the likelihood of a NASH patient progressing to cirrhosis and liver-related clinical events.
Owlstone Medical Entering Digestive Health Dx Space With Launch of Breath-Based Testing Service
Premium
The company is preparing to provide a clinical testing service that integrates hydrogen and methane biomarkers for digestive health conditions.
May 13, 2021
Apr 14, 2021
Aug 24, 2020
Fibronostics Raises $8M in Series A Round
Apr 29, 2020
DiscernDx Acquires Luminist Labs
Jun 11, 2019
Jan 3, 2019